CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Families and Children's Hospitals Urge Congressional Action on Pediatric Health Priorities
Family Advocacy Day brings families to Capitol Hill to highlight growing barriers to care, from Medicaid coverage to workforce shortages and youth mental health.
June 02, 2026
Where Kids’ Stories Help Guide Policy
Family Advocacy Day empowers children to share their experiences and help shape the future of pediatric care.
June 01, 2026
CHA Submits Letter on New NPI and Provider-Based Attestation Requirements
The letter emphasizes that the requirements would impose significant administrative, billing, and operational burden on children's hospitals.
May 26, 2026
